HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Christopher D O'Brien Selected Research

Metered Dose Inhalers (Metered Dose Inhaler)

8/2012Long-term safety and asthma control measures with a budesonide/formoterol pressurized metered-dose inhaler in African American asthmatic patients: a randomized controlled trial.
2/2012Budesonide/formoterol pressurized metered-dose inhaler versus budesonide: a randomized controlled trial in black patients with asthma.
9/2011Efficacy of budesonide/formoterol pressurized metered-dose inhaler versus budesonide pressurized metered-dose inhaler alone in Hispanic adults and adolescents with asthma: a randomized, controlled trial.
9/2010Once- vs twice-daily budesonide/formoterol in 6- to 15-year-old patients with stable asthma.
1/2010The safety and clinical benefit of budesonide/formoterol pressurized metered-dose inhaler versus budesonide alone in children.
9/2008Long-term safety and asthma control with budesonide/formoterol versus budesonide pressurized metered-dose inhaler in asthma patients.
5/2007Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma.
1/2006Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Christopher D O'Brien Research Topics

Disease

9Asthma (Bronchial Asthma)
08/2012 - 01/2006
2Respiratory Signs and Symptoms
04/2012 - 04/2012
2Inflammation
04/2012 - 04/2002
2Chronic Obstructive Pulmonary Disease (COPD)
04/2012 - 04/2012
1Headache (Headaches)
08/2012
1Nasopharyngitis
08/2012
1Respiratory Tract Infections (Respiratory Tract Infection)
08/2012
1Sinusitis
08/2012
1Disease Progression
04/2012
1Wounds and Injuries (Trauma)
10/2004
1Neoplasms (Cancer)
05/2002
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
05/2002

Drug/Important Bio-Agent (IBA)

9Budesonide (Pulmicort)FDA LinkGeneric
08/2012 - 01/2006
9formoterol (Oxis)FDA Link
08/2012 - 01/2006
4Adrenal Cortex Hormones (Corticosteroids)IBA
08/2012 - 01/2006
2Biological Markers (Surrogate Marker)IBA
04/2012 - 04/2012
2Leukocyte Elastase (Neutrophil Elastase)IBA
04/2012 - 04/2012
2CD31 AntigensIBA
10/2004 - 05/2002
1tiotropium (Spiriva)FDA Link
04/2012
1PaxillinIBA
10/2004
1Tyrosine (L-Tyrosine)FDA Link
10/2004
1AntibodiesIBA
05/2002
1cadherin 5IBA
05/2002
1glucuronyl glucosamine glycan sulfate (Vessel)IBA
05/2002
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
04/2002

Therapy/Procedure

8Metered Dose Inhalers (Metered Dose Inhaler)
08/2012 - 01/2006
2Dry Powder Inhalers
02/2012 - 01/2010
1Ambulatory Care (Outpatient Care)
01/2010
1Nebulizers and Vaporizers (Inhaler)
12/2009